The principle of providing equal care to all those who need it regardless of race, gender, age, socioeconomic status, and other differences is one of the pillars upholding the medical profession. It is hailed as a noble profession, not least because of its practitioners’ dedication to serving without bias or discrimination.
Unfortunately, medical practice and the science on which it is based are products of society and often reflect societal biases and inequalities. This is becoming more and more apparent as historical injustices are exposed and the medical community begins to reexamine and grow more conscious of its methods. Evidence of bias in healthcare is mounting, showing that the process of obtaining, analyzing, and interpreting health data is tainted by societal prejudice, and groups traditionally affected by bias, such as women and racial minorities, are also victims of health inequity to this day.
Bias in Health Research
The issue of bias in health data starts at the beginning – with the acquisition of data. Like in most other spheres of life, minorities, including women and racial minorities, are underrepresented in medical research. According to data from the United States Food and Drug Administration (FDA), 75% of research participants in the United States are white, while white people make up 60% of the population. In contrast, black people constitute 13% of the American population but are only 8% of research participants.
The National Institute of Health (NIH) in the US identified multiple potential reasons for this underrepresentation of minorities in medical research. One of the biggest reasons highlighted in this study is a lack of trust in the medical community, which is particularly prevalent in the black community due to a long history of racist and unethical medical experiments. Cases like the Tuskegee experiment, in which black people were given placebos and used to study the progression of syphilis without their knowledge, are still fresh in the collective memory of the African-American community. Low socioeconomic status and education level, both issues disproportionally affecting black people, are also linked to lower participation in research. Low educational levels are related to a lack of health education and awareness of clinical trials. Participating in trials also requires a time commitment and incurs various costs, which people of lower income often cannot afford.
Research in medicine also largely excludes women. For as long as it has existed, the medical field has disregarded or misunderstood women. It can be traced as far back as the beginnings of modern medicine, with ancient physicians using terms like “hysteria” (from the Greek and Latin words for “uterus”) to dismiss a wide range of ailments in women or attribute them to a malfunctioning uterus. Although hysteria as a diagnosis is no longer present in medical practice, sexism lingers in healthcare. Conditions that only affect women are misunderstood, underdiagnosed, and undertreated. Women’s bodies are considered similar to men’s bodies except for reproductive functions, leading to most research being conducted on male subjects. For this reason, diseases that present differently in women are often misdiagnosed and mismanaged.
On the other hand, when researchers acknowledge that women’s hormones and menstrual cycles make them different from men, it is still used as justification for the exclusion of women from medical studies with the claim that these differences would introduce too much variability into the study. This is also the case in animal studies, which focus predominantly on male subjects. Paradoxically, the recognition of biological differences between the sexes is limited to conducting studies, and scientific knowledge based on data from male study subjects is equally applied to women, causing them much harm. Gender bias is present in most of the medical science in use today as the United States FDA and NIH mandated the participation of women in human clinical trials only as recently as 1993. The NIH mandated the inclusion of female subjects in any animal trials it funded just eight years back in 2016.
Bias in Clinical Algorithms

Health data based on white males inevitably introduces bias into clinical practice, causing harm to underrepresented groups. Clinical algorithms used for decision-making are raising concerns in the medical community for having gender and racial biases. One area where current data puts women at a disadvantage is cardiovascular disease. Heart disease is traditionally considered a male issue, but research has found that women are more likely than men to have a heart attack misdiagnosed and more likely to die from one. As the knowledge of heart attack symptoms comes from studying men, women’s presentations are considered “atypical” and often easily missed. Clinical algorithms used to predict the risk of cardiovascular disease are also affected by similar gender bias. The Framingham Risk Score (FRS) is one of the most widely used tools for estimating the risk of developing coronary heart disease over ten years. However, research has shown that the FRS may underestimate cardiovascular risk in women.
Cardiovascular risk is also underestimated in black patients by biased clinical algorithms. The American Heart Association (AHA) Get with the Guidelines–Heart Failure Risk Score, which predicts the risk of death in patients admitted to the hospital, assigns three additional points to patients who identify as non-black. It underestimates the risk of death in black patients, making them less likely to get the necessary care. The AHA provides no rationale to back this adjustment. This was one of many illustrations of racial bias in clinical decision-making tools highlighted by a 2020 publication in the New England Journal of Medicine assessing the effect of race correction in clinical algorithms.
Another widely used clinical tool that is corrected for race and examined in the above study is the equation for estimated glomerular filtration rate (eGFR) from serum creatinine. The developers of the algorithm justify using race correction by citing higher baseline serum creatinine levels in black people. The algorithm yields higher eGFR values, suggesting better kidney function, for black patients. However, race correction of eGFR has come under scrutiny in recent years, prompting many US medical institutions to remove race adjustment. An assessment of the outcomes of this shift published in the Journal of the American Medical Association (JAMA) showed that the removal of race correction increased the number of black people being diagnosed with chronic kidney disease (CKD) and those referred to specialist care. More black patients also became eligible for kidney transplants.
As illustrated by these examples, race adjustment in clinical decision-making algorithms is controversial and likely contributes to creating further inequity in a healthcare system already compromised by biases. Researchers who incorporate race adjustment into the algorithms they develop often do so because when analyzing patient factors that may correlate with health outcomes, they find a significant correlation with race. However, establishing a causal relationship between race and health outcomes is more complex than that. Since race is as much a social concept as a biological one, it reflects racist societal structures and differences in socioeconomic status and access to healthcare. These confounding factors make it necessary for researchers and clinicians to be more discerning and critical when developing and using clinical tools.
- 5 Times Shark Tank Seen The Best of Medical Entrepreneurship (Doctorprenuership)New5 Times Shark Tank Seen The Best of Medical Entrepreneurship (Doctorprenuership)
Bias in AI Algorithms

Biased data poses a threat to the future of medicine as the field evolves and moves into the digital age. The algorithms used in new technology like artificial intelligence (AI) in healthcare depend on data and the quality of the data used can seriously compromise the algorithm’s ability to become an accurate and equitable tool.
Despite the relative novelty of AI, instances of it perpetuating societal bias have already begun to appear. A widely used algorithm that predicts healthcare needs to identify those with more complex health problems and in need of additional resources was found to be racially biased. The algorithm used past health expenditure as a proxy for health status, correlating spending more on healthcare in the past to higher risk and need for more care in the future. This put black people at a disadvantage as their healthcare expenses are influenced by other factors like socioeconomic status and access to healthcare, making them less likely to spend as much on healthcare as white patients even if they were sicker. The algorithm further exacerbated this inequity by shifting much-needed resources from the care of black patients.
Gender and racial bias have marred medical practice since the very beginning, harming countless patients. All the examples recounted here make that clear, but they also prove that the medical community is waking up to the problem of bias in healthcare. Reexamining and amending past injustices encourage more responsible collection, interpretation, and use of health data in the future, a promising step forward to a medical system free of bias and able to provide equal care to all.
- Importance of Medical Entrepreunership for Healthcare Quality ImprovementHOTImportance of Medical Entrepreunership for Healthcare Quality Improvement

